KDM4B and breast cancer: Depletion of KDM4B impairs the estrogen-induced G1/S transition in the cell cycle; and since KDM4B is a target of ER transcription, it may reflect a positive feedback loop that promotes hormone response to BC carcinogenesis (Shi et al., 2011).